JPRN-UMIN000025361
Unknown
未知
Clinical study about the ocular administration of the anti-VEGF antibody for the retinopathy of prematurity - Clinical study about the retinopathy of prematurity
ara Medical University0 sites20 target enrollmentJanuary 10, 2017
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- ara Medical University
- Enrollment
- 20
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Case of Retinal Detachment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical evaluation for the effects of intraocular tissue plasminogen activator administration in various eye diseasesVarious eye diseasesJPRN-UMIN000015726Department of Ophthalmology, Shimane University Faculty of Medicine, Izumo, Japan50
Recruiting
Not Applicable
Investigations of ocular side effects of topically applied 0.002% EYBELISJPRN-UMIN000039592Shohzankai Medical Foundation Miyake Eye Hospital80
Completed
Not Applicable
Ocular surface evaluation in ocular hypertension or inicial glaucoma patients treated with drops.Ocular hypertension or Open angle Glaucoma with no previous treatment.H40.0H40.1RBR-7mmp6kniversidade Federal de São Paulo
Completed
Not Applicable
Clinical study about the intraocular surgery using the adjuvant.The disease should be taken the intraocular surgery such as cataract or retina vitreous disease and others.JPRN-UMIN000029297Fujita Health University28
Completed
Not Applicable
Clinical research about intraocular injection of tissue plasminogen activator(cleactor)diabetes retinopathy,retina vein occlusion,macular degeneration,subretinal hemorrhage,macula edemaJPRN-UMIN000028467Fujita Health University75